{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:34:38Z","timestamp":1778715278840,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.vaccine.2008.04.044","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T13:31:05Z","timestamp":1210253465000},"page":"3497-3506","source":"Crossref","is-referenced-by-count":31,"title":["Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates"],"prefix":"10.1016","volume":"26","author":[{"given":"Donald L.","family":"Fine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara J.","family":"Terpening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"House","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.04.044_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Ann Rev Entomol"},{"key":"10.1016\/j.vaccine.2008.04.044_bib2","series-title":"Medical aspects of chemical and biological warfare","first-page":"561","author":"Smith","year":"1997"},{"key":"10.1016\/j.vaccine.2008.04.044_bib3","first-page":"79","article-title":"Venezuelan equine encephalitis","volume":"18","author":"Johnson","year":"1974","journal-title":"Adv Vet Sci Comp Med"},{"key":"10.1016\/j.vaccine.2008.04.044_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrmicro1006","article-title":"Transmission cycles, host range, evolution and emergence of arboviral disease","volume":"2","author":"Weaver","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.044_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1965.14.475","article-title":"Two human cases of laboratory infection with Mucambo virus","volume":"14","author":"de Mucha-Macias","year":"1965","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.044_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4269\/ajtmh.1979.28.329","article-title":"Ten clinical cases of human infection with Venezuelan equine encephalomyelitis virus, subtype I-D","volume":"28","author":"Dietz","year":"1979","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.044_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1006\/viro.1995.1197","article-title":"Mechanisms of neuroinvasion of Venezuelan equine encephalitis virus in the mouse","volume":"208","author":"Charles","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.04.044_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.04.044_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0042-6822(91)90114-Q","article-title":"Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone","volume":"183","author":"Davis","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.04.044_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0042-6822(89)90526-6","article-title":"In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of viable deletion mutant","volume":"171","author":"Davis","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.04.044_bib11","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.044_bib12","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.044_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.044_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/NeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2008.04.044_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.1999.60.1041","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates","volume":"60","author":"Turell","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.044_bib16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.044_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/infdis\/129.2.194","article-title":"Experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of Venezuelan equine encephalitis virus","volume":"129","author":"Monath","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.044_bib18","first-page":"209","article-title":"Attenuatioin of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells","volume":"73","author":"Berge","year":"1961","journal-title":"Am J Hyg"},{"issue":"43","key":"10.1016\/j.vaccine.2008.04.044_bib19","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1016\/j.vaccine.2007.07.061","article-title":"Chimeric sindbis\/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.04.044_bib20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0264-410X(01)00337-1","article-title":"Onset and duration of protective immunity to IA\/B and IE strains of Venezuelan equine encephalitis virus in vaccinated mice","volume":"20","author":"Hart","year":"2001","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800474X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800474X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T05:38:42Z","timestamp":1557553122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0800474X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":20,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0264410X0800474X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}